OssaTron
From Wikipedia, the free encyclopedia
The OssaTron is a high energy shock wave system that provides a non-surgical alternative for patients diagnosed with chronic proximal plantar fasciopathy (severe heel pain), usually referred to as fasciitis. Using a unique process known as Orthotripsy, the OssaTron emits shock waves, similar to those used to treat kidney stones, in an attempt to increase blood flow and stimulate healing of the affected heel.[1]
The OssaTron is the first shock wave unit developed especially for orthopaedic applications. The OssaTron covers a range of orthopaedic indications suitable for Shock Wave Technology. It is marketed as the only Extracorporeal Shock Wave Technology (ESWT) system approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple orthopaedic conditions. The OssaTron is currently FDA approved to treat chronic plantar fasciitis (heel pain) and chronic lateral epicondylitis (tennis elbow) when these conditions have failed to respond to conservative treatments.[2]
Procedure
Once anesthesia has been administered, high viscosity ultrasound gel is applied to the area experiencing pain (target tissue). The gel promotes shock wave conductance, enhancing treatment effectiveness. The Ossatron Application Technician then activates the shock wave via the shock wave release hand piece on the console.[1]